| Literature DB >> 31941868 |
Mutsuo Yamaya1, Genichiro Kawakami2, Haruki Momma3, Aya Yamada3, Jun Itoh2, Masakazu Ichinose4.
Abstract
Objective Pneumonia develops in bedridden patients, even in those receiving oral care, and malnutrition is associated with the development of pneumonia. We examined the effects of nutritional treatment on the prevention of pneumonia. Patients and Methods We retrospectively examined the effects of nutritional treatment on the prevention of pneumonia by analyzing the records of bedridden patients (n=68; mean age: 68.0 years) who stayed in a hospital for 2 years or longer. Results Among the analyzed patients, pneumonia developed in 52 (76%) patients, and the mean frequency of pneumonia was 1.6 times per year during the first year of stay. In a multivariate analysis, the serum albumin level at admission in the pneumonia group was lower than that in the non-pneumonia group. The frequency of pneumonia during the second year of stay was lower than that during the first year of stay. Serum levels of albumin and total protein (TP) at one year after admission were higher than those at admission in all analyzed patients, and in all patients (n=52) and elderly (≥65 years) patients (n=31) in the pneumonia group. The proportions of patients with hypoalbuminemia (<3.5 g/dL) and hypoproteinemia (<6.5 g/dL) at one year after admission were lower than those at admission. The increases in the proportions of patients presenting a reduced frequency of pneumonia were correlated with increases in the proportions of patients presenting increased levels of albumin and/or TP. Conclusion Nutritional treatment may reduce the frequency of pneumonia by improving malnutrition in bedridden patients receiving oral care.Entities:
Keywords: bedridden patients; malnutrition; nutritional treatment; oral care; prevention of pneumonia
Mesh:
Year: 2020 PMID: 31941868 PMCID: PMC7008047 DOI: 10.2169/internalmedicine.2966-19
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure.A schematic diagram outlining the patient selection process.
Patient Characteristics and Nutritional Supply.
| Characteristics, interventions, and effects | Analyzed patients | Pneumonia group | Non-pneumonia group | p value |
|---|---|---|---|---|
| Characteristics | ||||
| Number of patients, n | 68 | 52 | 16 | |
| Age (years, mean±SD) | 68.0±14.7 | 66.9±14.6 | 71.6±14.7 | 0.263 |
| Males, n (%)1) | 32 (47.1) | 26 (50.0) | 6 (37.5) | 0.381 |
| Oral care using a toothbrush, n (%)2) | 60 (88.2) | 46 (88.5) | 14 (87.5) | 0.609 |
| Oral care using wet gauze, n (%)2) | 7 (10.3) | 6 (11.5) | 1 (6.3) | 0.474 |
| Cause of hospitalization, n (%) | ||||
| ALS1) | 25 (36.8) | 20 (38.5) | 5 (31.3) | 0.601 |
| Cerebral infarction2) | 9 (13.2) | 7 (13.5) | 2 (12.5) | 0.645 |
| Muscular dystrophy2) | 9 (13.2) | 9 (17.3) | 0 (0.0) | 0.075 |
| COPD2) | 4 (4.4) | 2 (3.8) | 2 (12.5) | 0.233 |
| Others2,3) | 21 (30.9) | 16 (30.8) | 5 (31.3) | 0.599 |
| Comorbidities, n | ||||
| Pulmonary diseases1) | 23 (33.8) | 20 (38.5) | 3 (18.8) | 0.145 |
| Cardiovascular diseases1) | 22 (32.4) | 14 (26.9) | 8 (50.0) | 0.084 |
| Diabetes mellitus2) | 16 (23.5) | 13 (25.0) | 3 (18.8) | 0.442 |
| Hypertension2) | 12 (17.6) | 8 (15.4) | 4 (25.0) | 0.295 |
| Atrial fibrillation2) | 11 (16.2) | 7 (13.5) | 4 (25.0) | 0.233 |
| Cerebral infarction2) | 9 (13.2) | 9 (17.3) | 0 (0.0) | 0.075 |
| Epilepsy2) | 8 (11.8) | 7 (13.5) | 1 (6.3) | 0.391 |
| Others1,4) | 31 (45.6) | 24 (46.2) | 7 (43.8) | 0.866 |
| Number of death, n2) | 2 (2.9) | 2 (3.8) | 0 (0.0) | 1.000 |
| Treatment with drugs to improve the swallowing reflex, n (%)2) | 9 (13.2) | 9 (17.3) | 0 (0.0) | 0.075 |
| Treatment with ACEIs2) | 1 (1.5) | 1 (1.9) | 0 (0.0) | 0.765 |
| Treatment with dopamine analogs2) | 7 (10.3) | 7 (13.5) | 0 (0.0) | 0.138 |
| Treatment with cilostazol2) | 1 (1.5) | 1 (1.9) | 0 (0.0) | 0.765 |
| Treatment with PPIs2) | 7 (10.3) | 6 (11.5) | 1 (6.3) | 0.474 |
| Tube feeding, n (%)2) | 61 (89.7) | 48 (92.3) | 13 (81.3) | 0.204 |
| PEG tube feeding2) | 47 (69.1) | 37 (71.2) | 10 (62.5) | 0.358 |
| Nasogastric tube feeding2) | 14 (20.6) | 11 (21.2) | 3 (18.8) | 0.572 |
| IVH, n (%)2) | 2 (2.9) | 1 (1.9) | 1 (6.3) | 0.418 |
| Oral intake with assistance, n (%)2) | 5 (7.4) | 3 (5.8) | 2 (12.5) | 0.335 |
| Tracheostomy, n (%)2) | 50 (73.5) | 38 (73.1) | 12 (75.0) | 0.578 |
| Mechanical ventilation, n (%)1) | 41 (60.3) | 30 (57.7) | 11 (68.8) | 0.429 |
| Urinary catheterization, n (%)1) | 34 (50.0) | 24 (46.2) | 10 (62.5) | 0.253 |
| Pressure ulcer, n (%)1) | 28 (41.2) | 22 (42.3) | 6 (37.5) | 0.733 |
| Nutrition, K cal, mean±SD | 1,066±228 | 1,021±203 | 1,214±249 | 0.002 |
| Consciousness level, mean±SD | 12.9±3.5 | 12.6±3.7 | 13.8±2.7 | 0.215 |
For the comparison of continuous variables between the two groups, Student’s t-test, Pearson’s chi-squared test or Fisher’s exact test was used.
1)Pearson’s chi-squared test.
2)Fisher’s exact test.
3)The "Others" category includes cerebral palsy (n=3), Parkinson’s disease (n=3), tuberculous meningitis (n=3), cerebral bleeding (n=2), hypoxic encephalopathy (n=2), unresponsive wakefulness syndrome (n=1), brain contusion (n=1), Guillain-Barré syndrome (n=1), multiple system atrophy (n=1), syringomyelia (n=1), symptomatic epilepsy (n=1), traumatic cervical spinal cord injury (n=1), and brain tumor (n=1).
4)The "Others" category includes bladder stone, cancer, cholecystitis, cholelithiasis, chronic hepatitis, gastroduodenal ulcer, hydrocephalus, hyperthyroidism, hypothyroidism, hypoxic encephalopathy, intestinal obstruction, Parkinson’s disease, renal stone, schizophrenia and subdural hematoma.
ACEI: angiotensin-converting enzyme inhibitor, ALS: amyotrophic lateral sclerosis, IVH: intravenous hyperalimentation, PEG: percutaneous endoscopic gastrostomy, PPI: proton pump inhibitor
Physical Examination and Laboratory Findings at Baseline.
| Physical examination and laboratory data | All analyzed patients (n=68) | Pneumonia group (n=52) | Non- pneumonia group (n=16) | p value |
|---|---|---|---|---|
| Physical examinations and laboratory data at admission | ||||
| Physical examination | ||||
| BMI (mean±SD) | 17.8±3.6 | 17.6±3.6 | 18.6±3.6 | 0.324 |
| Laboratory data | ||||
| White blood cells (/μL, mean±SD) | 8,084±3,788 | 8,315±4,188 | 7,331±1,908 | 0.367 |
| Lymphocytes (/μL, mean±SD) | 1,665±657 | 1,704±662 | 1,538±642 | 0.382 |
| CRP (mg/dL, mean±SD) | 1.9±4.0 | 2.3±4.5 | 0.7±0.8 | 0.176 |
| Hb (g/dL, mean±SD) | 11.7±1.9 | 11.7±1.9 | 11.8±1.8 | 0.812 |
| Serum iron (μg/dL, mean±SD) | 50.6±23.8 | 53.5±24.8 | 42.0±19.1 | 0.214 |
| Total protein (g/dL, mean±SD) | 6.5±0.7 | 6.4±0.7 | 6.7±0.7 | 0.071 |
| Albumin (g/dL, mean±SD) | 3.2±0.5 | 3.1±0.5 | 3.4±0.6 | 0.028 |
| Total cholesterol (mg/dL mean±SD) | 160±38 | 157±40 | 172±31 | 0.179 |
| BUN (mg/dL, mean±SD) | 17.6±12.5 | 17.7±13.7 | 17.2±7.3 | 0.898 |
| Creatinine (mg/dL, mean±SD) | 0.41±0.28 | 0.38±0.26 | 0.54±0.32 | 0.045 |
| CPK (mg/dL, mean±SD) | 57.8±68.3 | 54.7±51.7 | 66.8±104.9 | 0.545 |
| Uric acid (mg/dL, mean±SD) | 3.6±1.9 | 3.4±1.7 | 4.3±2.4 | 0.108 |
| Proportion of patients, n (%) | ||||
| with>9,000 /μL WBC1) | 16 (23.5) | 14 (26.9) | 2 (12.5) | 0.200 |
| with<1,000 /μL lymphocytes1) | 8 (11.8) | 6 (11.5) | 2 (12.5) | 0.609 |
| with<6.5 g/dL total protein2) | 33 (48.5) | 29 (55.8) | 4 (25.0) | 0.031 |
| with<3.5 g/dL albumin1) | 48 (70.6) | 42 (80.8) | 6 (37.5) | 0.002 |
| with anemia2,3) | 44 (64.7) | 34 (65.4) | 10 (62.5) | 0.833 |
| with iron deficiency1,3) | 17 (47.2) | 12 (44.4) | 5 (55.6) | 0.423 |
| with high CRP1,3) | 51 (75.0) | 39 (75.0) | 12 (75.0) | 0.639 |
| with low uric acid2,3) | 25 (37.3) | 20 (39.2) | 5 (31.3) | 0.565 |
For the comparison of continuous variables between the two groups, Student’s t-test, Pearson’s chi-squared test or Fisher’s exact test was used.
Serum iron was measured in 26 patients in the pneumonia group and 9 patients in the nonpneumonia group. CPK was measured in 47 patients in the pneumonia group and 16 patients in the nonpneumonia group. Uric acid was measured in 51 patients in the pneumonia group and 16 patients in the nonpneumonia group.
1)Fisher’s exact test.
2)Pearson’s chi-squared test.
3)Anemia: <11.3 g/dL Hb in women, <13.5 g/dL Hb in men; iron deficiency: <43 μg/dL Fe in women, <54 μg/dL Fe in men; high CRP: >0.2 mg/dL; low uric acid: <2.3 μg/dL uric acid in women, <3.6 mg/dL uric acid in men.
BMI: body mass index, BUN: blood urea nitrogen, CPK: creatine phosphokinase, CRP: C-reactive protein, Hb: hemoglobin, WBC: white blood cells
Adjusted Mean (95% Confidence Intervals) Serum Albumin Levels among the Pneumonia and Non-pneumonia Groups.
| Pneumonia group | Non-pneumonia group | p for trend | |
|---|---|---|---|
| Crude | 3.10 (2.95, 3.24) | 3.43 (3.17, 3.69) | 0.028 |
| Model 1a) | 3.08 (2.95, 3.22) | 3.48 (3.23, 3.72) | 0.007 |
| Model 2b) | 3.09 (2.96, 3.23) | 3.45 (3.21, 3.70) | 0.012 |
| Model 3c) | 3.10 (2.96, 3.23) | 3.44 (3.19, 3.68) | 0.018 |
| Model 4d) | 3.10 (2.96, 3.23) | 3.44 (3.19, 3.69) | 0.018 |
| Model 5e) | 3.10 (2.97, 3.24) | 3.41 (3.16, 3.66) | 0.038 |
Values are presented as the estimated mean (95% CI).
a) Adjusted for age (continuous variable).
b) Additionally adjusted for consciousness level (continuous variable).
c) Additionally adjusted for tube feeding (no or yes).
d) Additionally adjusted for mechanical ventilation (no or yes).
e) Additionally adjusted for pulmonary diseases (no or yes).
Pathogens Identified in Patients in the Pneumonia Group.
| Number of patients | |
|---|---|
| Pathogen isolated | 471) |
| No pathogen isolated | 2 |
| No evaluated | 3 |
| Gram-positive pathogens | |
| 3 | |
| MSSA | 12 |
| MRSA | 7 |
| Gram-negative pathogens | |
| 4 | |
| 10 | |
| 41 | |
| 10 | |
| 14 | |
| 7 | |
| Other Gram-negative pathogens | 2 |
1)Two or more species of bacteria were identified in 28 patients.
Frequency of Pneumonia and Physical Examination and Laboratory Findings for All Analyzed Patients at the First and Second Years of Stay.
| Physical examination and laboratory data | First year | Second year | p value |
|---|---|---|---|
| Frequency of pneumonia1,2) (/year, mean±SD) | 1.6±1.5 | 0.7±0.9 | <0.001 |
| Physical examination and laboratory data2,3) | |||
| Physical examination | |||
| BMI (mean±SD) | 17.8±3.6 | 18.0±3.2 | 0.291 |
| Laboratory data | |||
| Total protein (g/dL, mean±SD) | 6.5±0.7 | 7.0±0.6 | <0.001 |
| Albumin (g/dL, mean±SD) | 3.2±0.5 | 3.4±0.5 | <0.001 |
| Total cholesterol (mg/dL mean±SD) | 160±38 | 160±27 | 0.990 |
| Hb (g/dL, mean±SD) | 11.7±1.9 | 11.5±1.9 | 0.235 |
| Serum iron (μg/dL, mean±SD) | 50.6±23.8 | 48.9±23.1 | 0.489 |
| Uric acid (mg/dL, mean±SD) | 3.6±1.9 | 3.7±1.8 | 0.635 |
| White blood cells (/μL, mean±SD) | 8,083±3,788 | 6,938±2,650 | 0.011 |
| Lymphocytes (/μL, mean±SD) | 1,665±657 | 1,798±719 | 0.094 |
| CRP (mg/dL, mean±SD) | 1.9±4.0 | 1.5±2.1 | 0.488 |
| Proportion of patients, n (%) | |||
| with <6.5 g/dL total protein | 33 (48.5) | 12 (17.6) | <0.001 |
| with <3.5 g/dL albumin | 48 (70.6) | 32 (47.1) | 0.001 |
| with anemia | 44 (64.7) | 43 (63.2) | 1.000 |
| with iron deficiency | 17 (47.2) | 7 (63.6) | 1.000 |
| with low uric acid | 25 (37.3) | 22 (36.1) | 0.804 |
| with >9,000 /μL WBC | 16 (23.5) | 12 (17.6) | 0.424 |
| with <1,000 /μL lymphocytes | 8 (11.8) | 9 (13.2) | 1.000 |
| with high CRP | 51 (75.0) | 51 (75.0) | 1.000 |
1)The frequency of pneumonia was measured by counting the frequency of pneumonia development during the first and second years of stay, separately.
2)For the comparison of variables between the first and second years of stay (frequency of pneumonia) and between the time of admission and one year after admission (BMI and laboratory data), paired t-tests and McNemar’s tests were used.
3)Laboratory data and BMI at admission and one year after admission are reported.
Characteristics, Frequency of Pneumonia, Physical Examination or Laboratory Findings Related to the Nutritional Condition of All or Elderly Patients in the Pneumonia Group during the First and Second Years of Stay.
| All patients in the pneumonia group (n=52) | First year | Second year | p value |
|---|---|---|---|
| Frequency of pneumonia1) (/year, mean±SD) | 2.1±1.3 | 0.9±1.0 | <0.001 |
| Physical examination and laboratory data2,3) | |||
| Physical examination | |||
| BMI (mean±SD) | 17.6±3.6 | 17.7±3.0 | 0.551 |
| Laboratory data | |||
| Total protein (g/dL, mean±SD) | 6.4±0.7 | 7.0±0.6 | <0.001 |
| Albumin (g/dL, mean±SD) | 3.1±0.5 | 3.4±0.5 | <0.001 |
| Total cholesterol (mg/dL mean±SD) | 157±40 | 161±27 | 0.459 |
| Proportion of patients, n (%) | |||
| with <6.5 g/dL total protein | 29 (55.8) | 10 (19.2) | <0.001 |
| with <3.5 g/dL albumin | 42 (80.8) | 27 (51.9) | 0.001 |
| Characteristics | |||
| Age (years, mean±SD) | 76.6±8.1 | - | - |
| Males, n (%) | 12 (38.7) | - | - |
| Frequency of pneumonia1,3) (/year, mean±SD) | 2.0±1.5 | 0.9±1.0 | <0.001 |
| Physical examinations and laboratory data2,3) | |||
| Physical examination | |||
| BMI (mean±SD) | 17.6±3.2 | 17.9±3.0 | 0.299 |
| Laboratory data | |||
| Total protein (g/dL, mean±SD) | 6.2±0.6 | 6.8±0.7 | <0.001 |
| Albumin (g/dL, mean±SD) | 3.0±0.5 | 3.3±0.5 | <0.001 |
| Total cholesterol (mg/dL, mean±SD) | 156±39 | 165±27 | 0.257 |
| Proportion of patients, n (%) | |||
| with <6.5 g/dL total protein | 21 (67.7) | 9 (29.0) | 0.004 |
| with <3.5 g/dL albumin | 28 (90.3) | 18 (58.1) | 0.006 |
1)The frequency of pneumonia was measured by counting the frequency of pneumonia development during the first and second years of stay, separately.
2)Laboratory data and BMI at admission and one year after admission are reported.
3)For the comparison of variables between the first and second years of stay (frequency of pneumonia) and between admission and one year after admission (BMI and laboratory data), paired t-tests and McNemar’s tests were used.
Relationship between Improvement in the Serum Levels of Albumin and Total Protein and the Decreased Frequency of Pneumonia in Patients in the Pneumonia Group.
| Number (%) of patients | p value3) | |||
|---|---|---|---|---|
| Decreased ALB1,2) | No change in ALB2) | Increased ALB2) | ||
| All pneumonia group patients (n=52) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 1 (1.9) | 2 (3.8) | 1 (1.9) | 0.003 |
| No change | 2 (3.8) | 1 (1.9) | 5 (9.6) | |
| Decrease | 2 (3.8) | 1 (1.9) | 36 (69.2) | |
| Elderly pneumonia group patients (n=31) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 1 (3.2) | 1 (3.2) | 1 (3.2) | 0.008 |
| No change | 1 (3.2) | 1 (3.2) | 2 (6.5) | |
| Decrease | 1 (3.2) | 1 (3.2) | 22 (71.0) | |
| All pneumonia group patients (n=52) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 2 (3.8) | 0 (0.0) | 2 (3.8) | 0.016 |
| No change | 2 (3.8) | 1 (1.9) | 5 (9.6) | |
| Decrease | 3 (5.8) | 3 (5.8) | 34 (65.4) | |
| Elderly pneumonia group patients (n=31) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 1 (3.2) | 0 (0.0) | 2 (6.5) | 0.269 |
| No change | 1 (3.2) | 0 (0.0) | 3 (9.7) | |
| Decrease | 2 (6.5) | 2 (6.5) | 20 (64.5) | |
1)ALB: serum albumin levels.
2)The term "Decreased" means that the values of TP and ALB at one year after admission were lower than those measured at the time of admission. The term "No change" means that the values of TP and ALB at one year after admission did not differ from those measured at the time of admission. Similarly, the term "Increased" means that the values of TP and ALB at one year after admission were higher than those measured at the time of admission.
3)Statistical analysis was performed using the chi-square test.
4)TP: serum total protein levels.
Relationship between Improvement in the Serum Levels of Albumin and Total Protein and the Decreased Frequency of Pneumonia in All Patients and All Elderly Patients in the Pneumonia and Non-pneumonia Groups.
| Number (%) of patients | p value3) | |||
|---|---|---|---|---|
| Decreased ALB1,2) | No change in ALB1,2) | Increased ALB1,2) | ||
| All patients (n=68) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 2 (2.9) | 2 (2.9) | 1 (1.5) | <0.001 |
| No change | 7 (10.3) | 3 (4.4) | 13 (19.1) | |
| Decrease | 2 (2.9) | 2 (2.9) | 36 (52.9) | |
| Elderly patients (n=44) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 2 (4.5) | 1 (2.3) | 1 (2.3) | 0.001 |
| No change | 5 (11.4) | 2 (4.5) | 9 (20.5) | |
| Decrease | 1 (2.3) | 1 (2.3) | 22 (50.0) | |
| All patients (n=68) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 3 (4.4) | 0 (0.0) | 2 (2.9) | 0.004 |
| No change | 5 (7.4) | 3 (4.4) | 15 (22.1) | |
| Decrease | 3 (4.4) | 3 (4.4) | 34 (50.0) | |
| Elderly patients (n=44) | ||||
| Changes in the frequency of pneumonia | ||||
| Increase | 2 (4.5) | 0 (0.0) | 2 (4.5) | 0.053 |
| No change | 4 (9.1) | 1 (2.3) | 11 (25.0) | |
| Decrease | 2 (4.5) | 2 (4.5) | 20 (45.5) | |
1)ALB: serum albumin levels.
2)The term "Decreased" means that the values of TP and ALB at one year after admission were lower than those measured at the time of admission. The term "No change" means that the values of TP and ALB at one year after admission did not differ from those measured at the time of admission. Similarly, the term "Increased" means that the values of TP and ALB at one year after admission were higher than those measured at the time of admission.
3)Statistical analysis was performed using the chi-square test.
4)TP: serum total protein levels.
Multivariate Analysis between the Changes in Serum Albumin Level and the Frequency of Pneumonia in All Patients.
| Albumin (ALB) | ||||
|---|---|---|---|---|
| Decrease of ALB | No change of ALB | Increase of ALB | p for trend | |
| Crude | 0.09 (-0.64, 0.82) | -0.14 (-1.05, 0.77) | -1.16 (-1.50, -0.82) | 0.003 |
| Model 1a) | 0.16 (-0.60, 0.92) | -0.09 (-1.05, 0.87) | -1.18 (-1.53, -0.83) | 0.003 |
Values are presented as the estimated mean (95% CI).
a)Adjusted for age (continuous variable), consciousness level (continuous variable), tube feeding (no or yes), mechanical ventilation (no or yes), pulmonary diseases (no or yes).